Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long covid/post-acute sequelae of covid-19 (pasc)

HIGHLIGHTS

• who: Etheresia Pretorius from the Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Private Bag, Matieland, Stellenbosch, South Africa have published the paper: Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC), in the Journal: (JOURNAL)
• what: The authors report on the comorbidities and persistent using data obtained from 845 South African patients. The authors show that hypertension, high cholesterol levels (dyslipidaemia) and T2DM are important comorbidities that may play a significant role in the development of Long COVID/PASC in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.